Izinzuzo Ezibonakalayo ZePycnogenol

Izinzuzo zezeMpilo, Ukusetshenziswa, Imiphumela emibi & Okuningi

I-Pycnogenol® (ebizwa ngokuthi i-pic-NOJ-en-all) yigama lebhizinisi lokukhishwa kwe-French maritime pine bark (i- Pinus pinaster ). Umthombo wemvelo wezinhlobo eziningana ze-antioxidants ezihlanganisa i-proanthocyanidins, etholakala ewayini, amagilebhisi, ama-apula, i-cocoa, itiye, amantongomane nezinye amajikijolo.

Okwenza Abantu Bisebenzise

I-Pycnogenol® ivame ukuthengiswa njengengxenye yokwengeza kwenhliziyo nempilo yokujikeleza kanye nezimo ezihlukahlukene:

Izinzuzo

Izifundo eziningi ze-pine bark extract zibe zincane futhi zesikhashana, futhi kufanele kuqashelwe ukuthi ezimbalwa zenziwe ngabacwaningi abazimele. Nakhu ukubuka kwesinye ucwaningo olutholakalayo:

Impilo Yenhliziyo

Ucwaningo oluthile lubonisa ukuthi i-Pycnogenol® ingase ikhuthaze ukugeleza kwegazi (ngokwandisa amazinga e-nitric oxide) futhi ngokuvamile ibhekwa njengesisombululo somfutho wegazi ophezulu, ukuvuvukala, nezinye izinkinga ezaziwa ukwandisa ingozi yesifo senhliziyo.

Ngokusho kocwaningo olwanyatheliswa ku- Archives of Internal Medicine , noma kunjalo, i-pine bark ekhishwe ingase ingabi ngcono impilo ye-heart. Lolu cwaningo lwabandakanya abantu abangu-130 abangaphezu kwesisindo somzimba, bonke ababenomfutho wegazi ophakeme kodwa abazange bathathe imishanguzo yegazi. Kwaphela amasonto angu-12, abahlanganyeli bathatha i-pine bark ekhishwe noma i-placebo.

Imiphumela yokufundwa ibonise ukuthi umfutho wegazi wezakhamuzi, amaprotheni asebenzayo e-C (uphawu lokuvuvukala), ushukela wegazi kanye namazinga e-cholesterol ahlala efana nawo wonke amaqembu kulo lonke ucwaningo.

Izifo zikaMeniere kanye nezintambo

I-Pycnogenol® ingasiza ekunakekeleni isifo seMeniere kanye ne-tinnitus, ngokusho kocwaningo olushicilelwe eMinerva Medica .

Kubhalwe ngomsindo oqhubekayo noma ukukhala ezindlebeni, i-tinnitus yinto evamile ngezinye izikhathi ezibangelwa umfutho ophansi noma ophakeme wegazi noma isifo esimisweni sokujikeleza.

Ukuze kuhlolwe, abahlanganyeli bathatha iPycnogenol® noma i-placebo nsuku zonke izinyanga eziyisithupha. Ngemuva kwezinyanga ezintathu, amaphesenti angu-45.4 alabo abathatha i-Pycnogenol® babengafani ngokuphelele uma kuqhathaniswa namaphesenti angu-23.07.

Ezinyangeni eziyisithupha, amaphesenti angu-87,3 alabo abathatha uPycnogenol® babengafani uma kuqhathaniswa nokulawula okungamaphesenti angama-34.6, futhi babe nokugeleza kwegazi okungcono kakhulu ku-cochlea (ingxenye yendlebe yangaphakathi edlala indima ebalulekile ekulaleleni). Ngenkathi i-tinnitus yehla emaqenjini womabili, ukwehla kwaba okubaluleke kakhulu kulabo abathatha i-Pycnogenol®.

Isifo sikashukela

I-Pycnogenol® ingasiza ekulawuleni ezinye izici ezingozini zenhliziyo kubantu abane-type 2 yesifo sikashukela, kuphakamisa isifundo esincane eshicilelwe ngo-2008. Kwaphela amasonto angu-12, abantu abangu-48 abanesifo sikashukela sohlobo lwesibili nomfutho wegazi ophakeme bathatha i-Pycnogenol® eyengeziwe noma iphilisi ye-placebo. Ngokuphela kokucwaninga, labo abathatha i-Pycnogenol® babonise ukuthuthukiswa komfutho wegazi, amazinga e- cholesterol , kanye namazinga kashukela egazi.

Ucwaningo lwamuva, olwanyatheliswa ngo-2009, lubonisa ukuthi i-Pycnogenol® ingathuthukisa umbono kubantu abasesimweni sokuqala se-retinopathy yesifo sikashukela.

Isibangela esiyinhloko sokuphuphuthekisa phakathi kwabantu abanesifo sikashukela, i-retinopathy yesifo sikashukela ivela lapho imithwalo yegazi evuza ewonakalisa i-retina (uhlaka oluthile olubonakalayo lwamashubhu ngemuva kweso elingaphakathi).

Ukuze kuhlolwe, abantu abanesifo sikashukela kanye ne-retinopathy esenesikhathi sokuqala bathatha iPycnogenol® noma i-placebo nsuku zonke izinyanga ezintathu. Imiphumela yokufundwa ibonise ukuthi abangu-18 kwabangu-24 ababambe iqhaza ababambe uPycnogenol® babe nokuthuthukiswa embonweni wabo, kuyilapho kungekho zithuthukisi ezinjalo ezitholwa kulabo abathatha i-placebo. Abalobi bezocwaningo basikisela ukuthi i-pine bark ekhishwe ingasiza ekuvuseleleni ukujikeleza ku-retina nokuvimbela ukuvuvukala, okuzokwenza ngcono umbono.

Thola ezinye izindlela zokwelapha zenyama yesifo sikashukela futhi ufunde amasu okuvimbela isifo sikashukela .

Njengoba i-Pycnogenol® ingase ihlaziye ushukela wegazi, uma ucabangela ukuyithatha, kubalulekile ukuthi ukhulume nomhlinzeki wakho wezempilo kuqala.

Ukungakwazi Ukwelashwa Okungapheliyo

Ucwaningo oluthile lubonisa ukuthi i-Pycnogenol® inganciphisa ukuvuvukala nobuhlungu kubantu abanezinkinga ezingenangqondo ezingapheli, isimo lapho imithanjeni ingabuyeli igazi ngokuphumelelayo emilenzeni kuya enhliziyweni.

Futhi funda ngokukhishwa kwembewu yamagilebhisi , umshanelo womhlanzi , i- chestnut yamahhashi , ne- rutin .

Ukungasebenzi Kwe-Erectile

I-Pycnogenol® ihlolwe njengendlela yokwelashwa kokusebenza kabi kwe-erectile, ngenxa yemiphumela yayo kumazinga we-nitric oxide nokugeleza kwegazi. Kodwa-ke, izifundo zisebenzise inhlanganisela ye-Pycnogenol® nezinye izithako (ikakhulukazi i-L-arginine), ngakho imiphumela ye-Pycnogenol®on eyakhe ngokwehluleka kwe-erectile ayiyaziwa.

Imiphumela emibi engenzeka kanye nokuphepha

I-Pycnogenol® ingase ibangele ukucasula kanye namazinga aphansi wezamandla, ikakhulu uma isetshenziselwa ukwelashwa kwe-ADHD.

Nakuba i-Pycnogenol® ngokuvamile ibhekwa njengophephile, ingase iphazamise isenzo semithi ethile esetshenziselwa ukwelashwa kwamakhemikhali kanye nokwelashwa kwemisebe.

Abantu abanezifo ezizimele, ezifana ne-rheumatoid arthritis, i-multiple sclerosis, i-lupus, nesifo se-celiac, kufanele bawugweme njengoba kungashukumisa isimiso somzimba.

I-Pycnogenol® ingakhuphula ingozi yokukhipha igazi, ngakho kufanele igwenywe yilabo abanezinkinga zokuphuma kwegazi, abantu abaphatha imithi yokwelashwa kwegazi noma ama-supplements, noma emasontweni ngaphambi kokuhlinzwa.

Khumbula ukuthi ukuphepha kwezidakamizwa kwabesifazane abakhulelwe, omama abahlengikazi, izingane, nalabo abanezimo zezokwelapha noma abaphuza imithi akuzange kusungulwe. Ungathola amathiphu ekusebenziseni izithako lapha . Ukwelapha isimo futhi ukugwema noma ukubambezela ukunakekelwa okujwayelekile kungaba nemiphumela emibi.

I-Takeaway

Nakuba kungase kube isilingo ukuzama lokhu kuhlolwa kwemithi yokuvimbela imithi elwa ne-antioxidant, emikhulu, emele. Uma usacabanga ngokuzama, qiniseka ukuthi uthintane nomhlinzeki wakho wezokunakekelwa kwezempilo kuqala ukulinganisa izinzuzo nezindleko bese uxoxisana ukuthi kukufanele yini.

> Imithombo:

> Cesarone MR, uBelcaro G, uRohdewald P, et al. Ukuqhathaniswa kwePycnogenol noDaflon ekunakekeleni ukungakwazi ukuphefumula okungapheliyo: isifundo esilawulwayo, esilawulwayo. I-Clin Appl Thromb Hemost. 2006 12 (2): 205-12.

> Drieling RL, CD Gardner, Ma J, Ahn DK, Stafford RS. Ayikho imiphumela ezuzisayo ye-pine bark ekhishwa ezinkingeni zesifo senhliziyo. I-Arch Intern Med. 2010 Sep 27; 170 (17): 1541-7.

> Luzzi R, uBelcaro G, Hu S, et al. Ukuthuthukisa izimpawu nokugeleza kwe-cochlear nge-pycnogenol ezigulini ezinezifo ze-Meniere ne-tinnitus. I-Minerva Med. 2014 Jun; 105 (3): 245-54.

> Steigerwalt R, uBelcaro G, uCesarone MR, et al. I-Pycnogenol ithuthukisa i-microcirculation, i-edema ye-retinal, nobuningi obubonakalayo ekutheni i-retinopathy yesifo sikashukela. J Ocul Pharmacol Ther. 2009 25 (6): 537-40.

> Zibadi S, uRohdewald PJ, Park D, Watson RR. Ukunciphisa izinkinga ze-cardiovascular risk in subjects ene-type 2 yesifo sikashukela nge-Pycnogenol supplementation. I-Nutr Res. 2008 (5): 315-20.

Ukuziphendulela: Ulwazi oluqukethwe kule sayithi luhloswe ngezinjongo zemfundo kuphela futhi aluthathi iseluleko, ukuxilongwa noma ukwelashwa ngudokotela olayisensi. Akuhloselwe ukumboza zonke izinyathelo zokuqapha, ukusebenzisana kwezidakamizwa, izimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.